Main Product Image

Lenvaxen 4 Mg (Lenvatinib)

Subcategory: Cancer

Lenvaxen 4 mg contains Lenvatinib, a potent oral tyrosine kinase asset( TKI) used in the operation of certain cancers. Lenvaxen is manufactured under strict pharmaceutical guidelines and is a reliable option for oncologists for the treatment of advanced cancers similar as thyroid cancer, HCC, and RCC. Lenvaxen exerts its action by blocking specific enzymes involved in the growth and spread of cancer cells, thereby inhibiting excrescence growth.

Medium of Action

Lenvatinib, the active substance in Lenvaxen, is a blocker of colorful receptor tyrosine kinases( RTKs) for excrescence angiogenesis( conformation of new blood vessels), cancer cell growth, and cancer cell progression. They include vascular endothelial growth factor receptors( VEGFR 1 – 3), fibroblast growth factor receptors( FGFR 1 – 4), platelet- deduced growth factor receptor nascence( PDGFRα), RET, and tackle. Blocking these receptors cuts off the excrescence's blood force and prevents or slows down its growth.

Suggestions and operation

Discerned: Thyroid Cancer( DTC) For the treatment of cases with progressing, locally advanced or metastatic DTC that's refractory to radioactive iodine( RAI) remedy.

Hepatocellular Carcinoma( HCC) As first- time treatment in adult cases with unresectable liver cancer.

Renal Cell Melanoma( RCC): With everolimus for the treatment of adult cases with advanced RCC after one previousanti-angiogenic remedy.

It should be noted that Lenvaxen should be administered under the supervision of a good health care provider who has experience with cancer treatment.

Lozenge and Administration

The cure and the suggested authority differ depending on the type of cancer and the case's weight. Lenvaxen is taken orally on a diurnal base with or without food. The 4 mg strength may be used in a combination remedy in a shot to achieve the needed cure on a diurnal base. Dosing must be acclimated grounded on case forbearance, adverse effects, and complaint response.

Possible Side effects

Like all effective cancer specifics, Lenvaxen 4 mg may have side effects. Commonest side goods are

Fatigue

Hypertension

Diarrhea

Loss of appetite

Weight loss

Nausea

Hand- bottom pattern

Less common but serious side goods may include liver dysfunction, cardiac issues, and proteinuria. Close monitoring and frequent follow- up with your oncologist is important in order to control these goods efficiently.

Preventives and Warnings

Cases who have a history of liver or order complaint, heart conditions, or taking multiple specifics should be informed beforehand by their croaker when they initiate Lenvaxen. Pregnant or suckling women must avoid this drug as it can be poisonous to the fetus or child. Other medicines may also interact with Lenvaxen, and hence a full list of ongoing specifics must be bared to the healthcare guru.

Storage and Handling

Store Lenvaxen 4 mg capsules at room temperature( 20 °C to 25 °C) down from humidity, heat, and sun. Keep out of reach of children.

Disclaimer 

This is for information purposes only and can not be used as a cover for professional medical advice. Always consult your croaker for substantiated advice regarding your condition and treatment.

Messenger WhatsApp Call